To summarise, the MR analysis showed that genetic elevation of CD160, DNPH1, LAYN, LRRC37A2 and TLR1 associated with breast cancer risk, and with similar effects on ER+ and ER− cancers. This evidence concerns the gene CD160 and breast cancer.